Pellets add a procedure plus a product. Distinguish FDA-approved pellet products (e.g., TESTOPEL, Schedule III) from compounded pellets and structure the full workflow.
Clinical governance reviewed by Armando A Falcon, MD (FL ME 84789) · Florida regulatory framework reviewed August 2026.
Yes, hormone-pellet therapy can be part of a properly structured medical practice, but “pellets” are not one uniform product category. Distinguish FDA-approved products from compounded pellet preparations, and define the procedural, prescribing, sourcing, documentation, aftercare, and complication-management workflow before launch.
TESTOPEL is a marketed prescription testosterone pellet product listed as Schedule III. Compounded hormone pellets are a separate product pathway and should not be presented as equivalent merely because both are implanted. Confirm the exact product.
Who prescribes, and who performs insertion — is the procedure within that practitioner’s scope? What training/competency is required? How are sterile technique and supplies handled? What aftercare is provided, what is the escalation pathway for infection, extrusion, or bleeding, and how is informed consent documented?
Adding pellets means adding both a medication service and an office procedure. Build both sides — product/sourcing and procedure/aftercare — before launch.
Disclaimer — B2B clinical-governance & compliance education only. This content is general business, clinical-governance, and compliance information for healthcare practices. It does not create a physician-patient relationship, provide patient-specific medical advice or prescribing authority, or constitute legal advice. Requirements vary by ownership, services offered, provider credentials, payer model, facility type, and whether a practice is licensed or exempt — clinics remain responsible for independently verifying the current laws, rules, and professional requirements that apply to their structure and services before implementation.
DailyMed — TESTOPEL (testosterone pellet) labeling
Florida Statutes §893.03 — Controlled-substance schedules
Florida Statutes Chapter 465 — Pharmacy Act (compounding & dispensing)
DailyMed (NIH) — FDA product labeling (verify route, warnings, contraindications)
Hormone Therapy (HRT · TRT · BHRT) — medical director services
All Florida medical-director resources
Medical director services across selected Central, South, and Gulf Coast Florida markets — Miami & Fort Lauderdale, Palm Beach County, Orlando, Tampa Bay, Sarasota & Bradenton, Fort Myers & Naples. See areas we serve. Clinic acceptance and physician availability are confirmed for each location.
Under the medical direction of Armando A Falcon, MD (FL ME 84789). Serving approved Central, South, and Gulf Coast Florida markets; clinic acceptance and physician availability confirmed individually. Call or WhatsApp +1 (305) 877-7507.